Concepts (152)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stomach Neoplasms | 18 | 2025 | 566 | 5.370 |
Why?
|
| Helicobacter Infections | 16 | 2025 | 1278 | 4.460 |
Why?
|
| Helicobacter pylori | 15 | 2025 | 1335 | 4.430 |
Why?
|
| Precancerous Conditions | 7 | 2023 | 288 | 2.870 |
Why?
|
| Barrett Esophagus | 7 | 2024 | 358 | 2.480 |
Why?
|
| Esophageal Neoplasms | 7 | 2024 | 396 | 2.070 |
Why?
|
| Adenocarcinoma | 6 | 2022 | 1071 | 2.060 |
Why?
|
| Early Detection of Cancer | 3 | 2024 | 414 | 1.500 |
Why?
|
| Veterans Health | 3 | 2020 | 179 | 1.290 |
Why?
|
| Proton Pump Inhibitors | 6 | 2025 | 285 | 1.260 |
Why?
|
| Metaplasia | 11 | 2023 | 219 | 1.250 |
Why?
|
| Stomach | 2 | 2022 | 271 | 1.200 |
Why?
|
| Esophagoscopy | 3 | 2024 | 165 | 1.110 |
Why?
|
| Demography | 3 | 2021 | 247 | 0.950 |
Why?
|
| Occult Blood | 1 | 2024 | 32 | 0.910 |
Why?
|
| Gastroenterologists | 1 | 2023 | 12 | 0.840 |
Why?
|
| Adenoma | 1 | 2024 | 143 | 0.820 |
Why?
|
| Anti-Bacterial Agents | 4 | 2025 | 2573 | 0.770 |
Why?
|
| Colonoscopy | 1 | 2024 | 249 | 0.770 |
Why?
|
| Risk Factors | 16 | 2024 | 11166 | 0.760 |
Why?
|
| Dyspepsia | 2 | 2022 | 108 | 0.710 |
Why?
|
| Communicable Diseases | 1 | 2023 | 164 | 0.710 |
Why?
|
| Ants | 1 | 2020 | 9 | 0.700 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2024 | 873 | 0.670 |
Why?
|
| Life Style | 2 | 2020 | 462 | 0.660 |
Why?
|
| Veterans | 4 | 2021 | 1782 | 0.660 |
Why?
|
| Flatulence | 1 | 2019 | 7 | 0.660 |
Why?
|
| Sigmoid Diseases | 1 | 2019 | 7 | 0.660 |
Why?
|
| Diverticulitis, Colonic | 1 | 2019 | 7 | 0.650 |
Why?
|
| Stomach Diseases | 1 | 2020 | 57 | 0.640 |
Why?
|
| Cross-Sectional Studies | 11 | 2022 | 3753 | 0.640 |
Why?
|
| Intestines | 2 | 2021 | 615 | 0.620 |
Why?
|
| Population Surveillance | 1 | 2022 | 419 | 0.620 |
Why?
|
| Mass Screening | 1 | 2025 | 840 | 0.620 |
Why?
|
| Intussusception | 1 | 2019 | 55 | 0.610 |
Why?
|
| Quality Improvement | 1 | 2025 | 700 | 0.600 |
Why?
|
| Esophagus | 1 | 2020 | 234 | 0.600 |
Why?
|
| Humans | 42 | 2025 | 134085 | 0.590 |
Why?
|
| Cicatrix | 1 | 2019 | 128 | 0.590 |
Why?
|
| Colorectal Neoplasms | 1 | 2024 | 652 | 0.580 |
Why?
|
| Diverticulitis | 1 | 2018 | 8 | 0.580 |
Why?
|
| Middle Aged | 18 | 2025 | 29402 | 0.560 |
Why?
|
| Duodenal Diseases | 1 | 2018 | 34 | 0.560 |
Why?
|
| Electronic Health Records | 1 | 2025 | 796 | 0.560 |
Why?
|
| Aged | 14 | 2025 | 21756 | 0.530 |
Why?
|
| United States | 12 | 2025 | 11750 | 0.530 |
Why?
|
| Incidence | 5 | 2024 | 3414 | 0.530 |
Why?
|
| Colitis, Ulcerative | 2 | 2016 | 217 | 0.520 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2019 | 245 | 0.520 |
Why?
|
| Gastritis | 1 | 2019 | 373 | 0.510 |
Why?
|
| Crohn Disease | 2 | 2016 | 290 | 0.510 |
Why?
|
| Endoscopy, Digestive System | 1 | 2016 | 159 | 0.480 |
Why?
|
| Biopsy | 4 | 2024 | 1303 | 0.480 |
Why?
|
| Abdominal Pain | 1 | 2018 | 314 | 0.480 |
Why?
|
| Gastroesophageal Reflux | 1 | 2016 | 337 | 0.410 |
Why?
|
| Texas | 4 | 2024 | 3715 | 0.400 |
Why?
|
| Diet | 1 | 2020 | 1194 | 0.400 |
Why?
|
| Male | 18 | 2025 | 66057 | 0.400 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2016 | 328 | 0.390 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2016 | 475 | 0.380 |
Why?
|
| Drug Therapy, Combination | 2 | 2025 | 1199 | 0.340 |
Why?
|
| Prevalence | 4 | 2020 | 2684 | 0.330 |
Why?
|
| Female | 16 | 2025 | 71851 | 0.320 |
Why?
|
| Predictive Value of Tests | 3 | 2024 | 2301 | 0.300 |
Why?
|
| Retrospective Studies | 9 | 2024 | 17518 | 0.300 |
Why?
|
| Case-Control Studies | 3 | 2020 | 3665 | 0.280 |
Why?
|
| Aged, 80 and over | 4 | 2020 | 7207 | 0.270 |
Why?
|
| Gastroscopy | 2 | 2023 | 100 | 0.250 |
Why?
|
| Neoplasms | 1 | 2020 | 3037 | 0.230 |
Why?
|
| Adult | 6 | 2025 | 31964 | 0.230 |
Why?
|
| Iodides | 1 | 2024 | 15 | 0.230 |
Why?
|
| Coloring Agents | 1 | 2024 | 78 | 0.230 |
Why?
|
| China | 1 | 2024 | 296 | 0.210 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2023 | 244 | 0.210 |
Why?
|
| Colonic Polyps | 1 | 2024 | 83 | 0.210 |
Why?
|
| Cost-Benefit Analysis | 1 | 2025 | 563 | 0.200 |
Why?
|
| SEER Program | 1 | 2023 | 224 | 0.190 |
Why?
|
| Hospitals | 1 | 2025 | 437 | 0.190 |
Why?
|
| Risk Assessment | 3 | 2020 | 3729 | 0.190 |
Why?
|
| Practice Guidelines as Topic | 2 | 2025 | 1340 | 0.180 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2019 | 2196 | 0.170 |
Why?
|
| Emigrants and Immigrants | 1 | 2022 | 154 | 0.170 |
Why?
|
| Diet Records | 1 | 2020 | 76 | 0.170 |
Why?
|
| Esophageal Mucosa | 1 | 2020 | 12 | 0.160 |
Why?
|
| Nutritive Value | 1 | 2020 | 93 | 0.160 |
Why?
|
| Colon, Sigmoid | 1 | 2019 | 14 | 0.160 |
Why?
|
| Dietary Fiber | 1 | 2020 | 83 | 0.160 |
Why?
|
| Colostomy | 1 | 2019 | 28 | 0.160 |
Why?
|
| Histamine H2 Antagonists | 1 | 2019 | 50 | 0.160 |
Why?
|
| Dietary Carbohydrates | 1 | 2020 | 117 | 0.160 |
Why?
|
| Sensitivity and Specificity | 3 | 2020 | 2171 | 0.160 |
Why?
|
| Colectomy | 1 | 2019 | 84 | 0.150 |
Why?
|
| Healthcare Disparities | 1 | 2024 | 480 | 0.150 |
Why?
|
| Rectum | 1 | 2019 | 113 | 0.150 |
Why?
|
| Smoking | 3 | 2023 | 1136 | 0.150 |
Why?
|
| Lipoproteins, HDL | 1 | 2019 | 118 | 0.150 |
Why?
|
| Alcohol Drinking | 1 | 2021 | 387 | 0.150 |
Why?
|
| Research | 1 | 2020 | 273 | 0.150 |
Why?
|
| Fruit | 1 | 2020 | 237 | 0.150 |
Why?
|
| Logistic Models | 2 | 2021 | 1909 | 0.150 |
Why?
|
| Proton Pumps | 1 | 2018 | 11 | 0.150 |
Why?
|
| Duodenoscopy | 1 | 2018 | 13 | 0.150 |
Why?
|
| Energy Intake | 1 | 2020 | 518 | 0.140 |
Why?
|
| Duodenum | 1 | 2018 | 110 | 0.140 |
Why?
|
| Odds Ratio | 1 | 2020 | 1338 | 0.130 |
Why?
|
| Costs and Cost Analysis | 1 | 2016 | 165 | 0.130 |
Why?
|
| Intravital Microscopy | 1 | 2016 | 19 | 0.130 |
Why?
|
| Computers, Handheld | 1 | 2016 | 33 | 0.120 |
Why?
|
| Epithelial Cells | 1 | 2020 | 937 | 0.120 |
Why?
|
| Software | 1 | 2020 | 733 | 0.120 |
Why?
|
| Age of Onset | 1 | 2016 | 637 | 0.120 |
Why?
|
| Treatment Outcome | 2 | 2023 | 13051 | 0.120 |
Why?
|
| Intensive Care Units | 1 | 2019 | 538 | 0.120 |
Why?
|
| United States Department of Veterans Affairs | 2 | 2019 | 707 | 0.110 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2016 | 238 | 0.110 |
Why?
|
| Recurrence | 1 | 2018 | 1472 | 0.110 |
Why?
|
| International Classification of Diseases | 1 | 2014 | 100 | 0.100 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 1317 | 0.100 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 1007 | 0.090 |
Why?
|
| Cell Cycle | 1 | 2013 | 627 | 0.090 |
Why?
|
| Neoplastic Stem Cells | 1 | 2013 | 352 | 0.080 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 1417 | 0.080 |
Why?
|
| Prospective Studies | 1 | 2020 | 6602 | 0.080 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 3104 | 0.070 |
Why?
|
| Gastric Mucosa | 2 | 2022 | 492 | 0.070 |
Why?
|
| Surveys and Questionnaires | 1 | 2016 | 3999 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2013 | 951 | 0.060 |
Why?
|
| Optical Fibers | 1 | 2024 | 19 | 0.060 |
Why?
|
| Gastrectomy | 1 | 2024 | 103 | 0.050 |
Why?
|
| Prognosis | 2 | 2024 | 5085 | 0.050 |
Why?
|
| Minority Groups | 1 | 2023 | 256 | 0.050 |
Why?
|
| Guideline Adherence | 1 | 2024 | 399 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2024 | 616 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2024 | 5206 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2013 | 4934 | 0.040 |
Why?
|
| Animals | 1 | 2020 | 36543 | 0.040 |
Why?
|
| Survival Rate | 1 | 2024 | 2218 | 0.040 |
Why?
|
| Algorithms | 2 | 2016 | 1736 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2024 | 5477 | 0.030 |
Why?
|
| Mobile Applications | 1 | 2016 | 109 | 0.030 |
Why?
|
| Registries | 1 | 2019 | 1577 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 399 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2013 | 440 | 0.020 |
Why?
|
| Obesity | 1 | 2022 | 2446 | 0.020 |
Why?
|
| Time Factors | 1 | 2019 | 6604 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2013 | 796 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 3043 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 1922 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2013 | 2561 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 3797 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 2136 | 0.010 |
Why?
|
| Child | 1 | 2013 | 25843 | 0.010 |
Why?
|